Time course of hepatitis E-specific antibodies in adults

Journal of Viral Hepatitis

Volumn 24, Issue 1, 2017, Pages 75-79

  Schemmerer, M ^a   Rauh, C ^a   Jilg, W ^a   Wenzel, J J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

anti HEV IgG; antibody dynamics; hepatitis E virus; negative seroconversion; reinfection

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; HEPATITIS ANTIBODY; IMMUNOGLOBULIN G;

ADULT; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FEMALE; FOLLOW UP; HEPATITIS E; HUMAN; MALE; PRIORITY JOURNAL; REINFECTION; SEROCONVERSION; BLOOD; IMMUNOLOGY; LONGITUDINAL STUDY; MIDDLE AGED; TIME FACTOR; YOUNG ADULT;

ADULT; AGED; FEMALE; HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; IMMUNOGLOBULIN G; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; TIME FACTORS; YOUNG ADULT;

EID: 84994805459     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12621     Document Type: Article

References (15)

1. Smith DB, Simmonds P; International Committee on Taxonomy of Viruses Hepeviridae Study Group, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2014;95:2223–2232.
2. Van der Poel WH. Food and environmental routes of Hepatitis E virus transmission. Curr Opin Virol. 2014;4:91–96.
3. Li TC, Chijiwa K, Sera N, et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis. 2005;11:1958–1960.
4. Wenzel JJ, Preiss J, Schemmerer M, Huber B, Plentz A, Jilg W. Detection of hepatitis E virus (HEV) from porcine livers in Southeastern Germany and high sequence homology to human HEV isolates. J Clin Virol. 2011;52:50–54.
5. Faber MS, Wenzel JJ, Jilg W, Thamm M, Hohle M, Stark K. Hepatitis E virus seroprevalence among adults, Germany. Emerg Infect Dis. 2012;18:1654–1657.
6. Hogema BM, Molier M, Slot E, Zaaijer HL. Past and present of hepatitis E in the Netherlands. Transfusion. 2014;54:3092–3096.
7. Mansuy JM, Bendall R, Legrand-Abravanel F, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis. 2011;17:2309–2312.
8. Dalton HR, Bendall R, Ijaz S, Banks M. Hepatitis E: An emerging infection in developed countries. Lancet Infect Dis. 2008;8:698–709.
9. Huang S, Zhang X, Jiang H, et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS One. 2010;5:e13560.
10. Servant-Delmas A, Abravanel F, Lefrere JJ, et al. New insights into the natural history of hepatitis E virus infection through a longitudinal study of multitransfused immunocompetent patients in France. J Viral Hepat. 2016;23:569–575.
11. Ferguson M, Walker D, Mast E, Fields H. Report of a collaborative study to assess the suitability of a reference reagent for antibodies to hepatitis E virus. Biologicals. 2002;30:43–48.
12. Bendall R, Ellis V, Ijaz S, Thurairajah P, Dalton HR. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol. 2008;80:95–101.
13. Zhang J, Shih JW, Xia NS. Long-term efficacy of a hepatitis E vaccine. N Engl J Med. 2015;372:2265–2266.
14. Zhu FC, Zhang J, Zhang XF, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: A large-scale, randomized, double-blind placebo-controlled, phase 3 trial. Lancet. 2010;376:895–902.
15. Abravanel F, Lhomme S, Chapuy-Regaud S, et al. Hepatitis E virus reinfections in solid-organ-transplant recipients can evolve into chronic infections. J Infect Dis. 2014;209:1900–1906.